Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-12-18
1994-07-05
Springer, David B.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
549479, 549 55, 514473, 514427, 514640, 562623, 548561, C07D30758, C07D33332, A61K 3134, A61K 3138
Patent
active
053268830
ABSTRACT:
The present invention provides certain substituted oxime ether compounds which inhibit lipoxygenase enzyme activity and are useful in the treatment of allergic and inflammatory disease states. The compounds of this invention have the structure ##STR1## where M is hydrogen, a pharmaceutically acceptable cation, or a pharmaceutically acceptable metabolically cleavable group; p and q are independently zero or one, with the provisos that (i) p and q may not both be the same; (ii) when p is one and q is zero, R is selected from the group consisting of hydrogen, straight or branched alkyl of from one to twelve carbon atoms, and cycloalkyl of from three to eight carbon atoms; and (iii) when p is zero and q is one, R is selected from the group consisting of hydrogen, alkyl of from one to twelve carbon atoms, cycloalkyl of from three to eight carbon atoms, and --NR.sub.1 R.sub.2.
L.sub.1 is a direct bond or is selected from the group consisting of alkyl of from one to six carbon atoms, alkylenyl, of from one to six carbon atoms, and alkynyl of from two to six carbon atoms; L.sub.2 is a direct bond or is alkyl of from one to six carbon atoms; Z is selected from the group consisting of hydrogen, alkyl of from one to six carbon atoms, and halosubstituted alkyl of from one to six carbon atoms; and A is optionally substituted carbocyclic or heterocyclic aryl, arylalkyl, or aryloxy.
REFERENCES:
patent: 4144245 (1979-03-01), Cale
patent: 5169854 (1992-12-01), Brooks et al.
patent: 5240958 (1993-08-01), Campion et al.
Brooks Dee W.
Maki Robert G.
Stewart Andrew O.
Abbott Laboratories
Janssen Jerry F.
Springer David B.
LandOfFree
Oxime ether derivatives having lipoxygenase inhibitory activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxime ether derivatives having lipoxygenase inhibitory activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxime ether derivatives having lipoxygenase inhibitory activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-797067